Synopsis
Motivation:
Goals:
Approach:
Results:
563-03-002
ISMRM Abstract
A Comparison of Radio-Pathomic, Diffusion, and Perfusion Imaging Features for Identifying Pseudoprogression in Gliomas
Accepted
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
Log inReferences
1. Ostrom QT, Cioffi G, Gittleman H, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. Neuro Oncol. 2019;21(Suppl 5):v1-v100. doi:10.1093/neuonc/noz150 [doi]
2. Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS. Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014. JAMA Oncol. 2018;4(9):1254-1262. doi:10.1001/jamaoncol.2018.1789 [doi]
3. Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol. 2013;15 Suppl 2(Suppl 2):ii1-56. doi:10.1093/neuonc/not151 [doi]
4. Margiewicz S, Cordova C, Chi AS, Jain R. State of the Art Treatment and Surveillance Imaging of Glioblastomas. Semin Roentgenol. 2018;53(1):23-36. doi:10.1053/j.ro.2017.11.003 [doi]
5. Zikou A, Sioka C, Alexiou GA, Fotopoulos A, Voulgaris S, Argyropoulou MI. Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas. Contrast Media Mol Imaging. 2018;2018:6828396. doi:10.1155/2018/6828396 [doi]
6. Abdulla S, Saada J, Johnson G, Jefferies S, Ajithkumar T. Tumour progression or pseudoprogression? A review of post-treatment radiological appearances of glioblastoma. Clin Radiol. 2015;70(11):1299-1312. doi:10.1016/j.crad.2015.06.096 [doi]
7. Choi YJ, Kim HS, Jahng GH, Kim SJ, Suh DC. Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging. Acta radiol. 2013;54(4):448-454. doi:10.1177/0284185112474916 [doi]
8. Bobholz SA, Lowman AK, Brehler M, et al. Radio-Pathomic Maps of Cell Density Identify Brain Tumor Invasion beyond Traditional MRI-Defined Margins. AJNR Am J Neuroradiol. 2022;43(5):682-688. doi:10.3174/ajnr.A7477 [doi]
9. Bobholz SA, Lowman AK, Connelly JM, et al. Noninvasive Autopsy-Validated Tumor Probability Maps Identify Glioma Invasion Beyond Contrast Enhancement. Neurosurgery. 2024;95(3). doi: 10.1227/neu.0000000000002898. [doi]
10. Bobholz SA, Aaronson D, Winiarz A, et al. Multi-Site Retrospective Analysis of Diffusion and Perfusion MRI Correlates to Glioma Characteristics Derived from Radio-Pathomic Maps. Neuro Oncol. Published online February 17, 2025:noaf044. doi:10.1093/neuonc/noaf044 [doi]
11. Bobholz SA, Hoefs A, Hamburger J, et al. Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response. J Neurooncol. Published online 2024. doi:10.1007/s11060-024-04593-7 [doi]
Cite this abstract
http://echo.ismrm.org/p/ISMRM2026/563-03-002